Dehydrocrebanine is primarily studied for its potential biological activities, particularly in the field of pharmacology. It has shown notable anti-inflammatory and analgesic effects in preclinical studies, making it a candidate for development in pain management therapies. Research also indicates that the compound may possess neuroprotective properties, suggesting possible applications in treating neurodegenerative conditions such as Alzheimer’s or Parkinson’s disease. Additionally, it has demonstrated mild sedative effects, which could be explored for use in anxiety or sleep disorders. Due to its structural characteristics, dehydrocrebanine serves as a lead compound in the synthesis of derivatives aimed at enhancing potency and selectivity for specific biological targets. Most of the current applications remain in the experimental stage, with ongoing research focused on elucidating its mechanisms of action and therapeutic potential.